Literature DB >> 2871100

In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci.

E Debbia, A Pesce, G C Schito.   

Abstract

In this study we have evaluated the in vitro activity of teicoplanin, a potent anti-staphylococcal and anti-enterococcal agent, in combination with rifampicin, netilmicin, amikacin, fosfomycin and imipenem. Drug interactions were assessed using a microtitre checkerboard dilution method and a time-kill test. With rifampicin, indifference or an additive effect was the prevalent outcome with both methods. With netilmicin and amikacin synergism was seen against half of the enterococcal strains, whereas indifference was more common with staphylococcal isolates. Synergism predominated when teicoplanin was combined with fosfomycin and imipenem. Under no circumstances and with no combination of drugs were we able to detect antagonistic effects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871100     DOI: 10.1016/0195-6701(86)90010-1

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

1.  In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  J G Barr; E T Smyth; G M Hogg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

Review 2.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

3.  Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis.

Authors:  M J Rybak; S A Lerner; D P Levine; L M Albrecht; P L McNeil; G A Thompson; M T Kenny; L Yuh
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.